[Considerations on antacid therapy].
D000536:Aluminum Hydroxide / Q000009:adverse effects; D000863:Antacids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001927:Brain Diseases / Q000139:chemically induced; D002119:Calcium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D003248:Constipation / Q000139:chemically induced; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced; D007408:Intestinal Absorption; D008276:Magnesium Hydroxide / Q000009:adverse effects / Q000627:therapeutic use; D010710:Phosphates / Q000378:metabolism; D006435:Renal Dialysis; D013997:Time Factors
D000863:Antacids; D010710:Phosphates; D000536:Aluminum Hydroxide; D002119:Calcium Carbonate; D008276:Magnesium Hydroxide
Uberlegungen zur Therapie mit Antacida.